Navigation Links
'Heart' of Herschel to be presented to media
Date:9/4/2007

By the end of 2007, the assembly of the ESA's Herschel far-infrared space observatory - the latest mission to study the formation and evolution of stars and galaxies - will be completed.

ESA and Astrium are jointly inviting the media to a press conference in Friedrichshafen, Germany, on 19 September 2007, to hear about this revolutionary spacecraft, its scientific objectives, and to view the very heart of its hardware.

The Herschel mission, equipped with the largest telescope ever launched in space (3.5 m diameter), will give astronomers their best capability yet to explore the universe at far-infrared and sub-millimetre wavelengths. By measuring the light at these wavelengths, scientists see the 'cold' universe. Herschel will give them an unprecedented view, allowing them to see deep into star forming regions, galactic centres and planetary systems.

In order to achieve its objectives and to be able to detect the faint radiation coming from the coolest objects in the cosmos, otherwise 'invisible', Herschel's detectors must operate at very low and stable temperatures. The spacecraft is equipped so as to cool them close to absolute zero (-273.15 C), ranging from -271 C to only a few tenths of a degree above absolute zero. To have achieved this particular feature alone is a remarkable accomplishment for European industry and science.

The final integration of the various components of the Herschel spacecraft - payload module, cryostat, service module, telescope and solar arrays - will be completed in the next few months. This phase will be followed by a series of tests to get the spacecraft ready for launch at the end of July 2008. Herschel will be launched into space on an Ariane 5 ECA rocket. The launch is shared with Planck, ESA's mission to study relic radiation from the Big Bang.


'/>"/>

Contact: ESA Media Relations Office
media@esa.int
33-015-369-7299
European Space Agency
Source:Eurekalert

Page: 1

Related biology news :

1. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
2. UCSD team discovers specialized, rare heart stem cells in newborns
3. Implanted Devices Detect High-Risk Heart Failure Patients
4. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
5. Special Imaging Study Shows Failing Hearts Are Energy Starved
6. Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks
7. Single stem cells from bone heal a broken heart
8. Heart repair gets new muscle
9. Python a hearty eater
10. Columbia study shows widely used artery clearing device does not help patients during heart attack
11. Researchers reveal secret of key protein in brain and heart function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... -- New research undertaken by Fit Small Business has ... were simply asked which office technology had they not used ... issue.  Insights on what will be key features ... and industry leaders including Penelope Trunk , Martin ... Some of these findings included; ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/4/2017)... 2017  CES 2017 – Valencell , the ... announced the launch of two new versions of ... biometric sensor modules that incorporate the best of ... expertise. The two new designs include Benchmark BE2.0, ... and Benchmark BW2.0, a 2-LED version of its ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... YORK , January 20, 2017 ... Organization, cancer is one of leading causes of death ... 2012. Although the number of cancer related deaths increased ... 1990. Rising in incidence rate of various cancers continues ... to a research report by Global Market Insights, Inc. ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi ... device open-access capability and technology platform, today announced ... leading biology focused preclinical drug discovery contract research ... will become a wholly-owned subsidiary of WuXi, and ... competences and providing greater services. The acquisition will ...
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... Minnesota (PRWEB) , ... January 19, 2017 , ... ... research organization with services spanning the full spectrum of drug and device development, ... research services to pharma/device companies and clinicians, today announced Verified Clinical Trials ...
Breaking Biology Technology: